Elevated brain iron is independent from atrophy in Huntington's Disease

Increased iron in subcortical structures in patients with Huntington's Disease (HD) has been suggested as a causal factor of neuronal degeneration. The present study examines iron accumulation, measured using magnetic resonance imaging (MRI), in premanifest gene carriers and in early HD patients as compared to healthy controls. In total 27 early HD patients, 22 premanifest gene carriers and 25 healthy controls, from the Leiden site of the TRACK-HD study, underwent 3T MRI including high resolution 3D T(1)- and T(2)-weighted and asymmetric spin echo (ASE) sequences. Magnetic Field Correlation (MFC) maps of iron levels were constructed to assess magnetic field inhomogeneities and compared between groups in the caudate nucleus, putamen, globus pallidus, hippocampus, amygdala, accumbens nucleus, and thalamus. Subsequently the relationship of MFC value to volumetric data and disease state was examined. Higher MFC values were found in the caudate nucleus (p<0.05) and putamen (p<0.005) of early HD compared to controls and premanifest gene carriers. No differences in MFC were found between premanifest gene carriers and controls. MFC in the caudate nucleus and putamen is a predictor of disease state in HD. No correlation was found between the MFC value and volume of these subcortical structures. We conclude that Huntington's disease patients in the early stages of the disease, but not premanifest gene carriers, have higher iron concentrations in the caudate nucleus and putamen. We have demonstrated that the iron content of these structures relates to disease state in gene carriers, independently of the measured volume of these structures.

[1]  Gary Lynch,et al.  Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease , 2007, Glia.

[2]  J. Schenck,et al.  High‐field magnetic resonance imaging of brain iron: birth of a biomarker? , 2004, NMR in biomedicine.

[3]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[4]  G A Johnson,et al.  MRI of brain iron. , 1986, AJR. American journal of roentgenology.

[5]  Sven Haller,et al.  Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. , 2010, Radiology.

[6]  Marian DiFiglia,et al.  Huntington Disease , 1998, Journal of neuropathology and experimental neurology.

[7]  S. Fahn,et al.  Huntington disease , 1979, Neurology.

[8]  Jane S. Paulsen,et al.  Brain Structure in Preclinical Huntington’s Disease , 2006, Biological Psychiatry.

[9]  E. Růžička,et al.  MR relaxometry in Huntington's disease: Correlation between imaging, genetic and clinical parameters , 2007, Journal of the Neurological Sciences.

[10]  R. Roos,et al.  Neuronal distribution in the putamen in Huntington's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[11]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[12]  Y Ge,et al.  Brain Iron Quantification in Mild Traumatic Brain Injury: A Magnetic Field Correlation Study , 2011, American Journal of Neuroradiology.

[13]  J A Helpern,et al.  Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.

[14]  Glyn Johnson,et al.  Magnetic field correlation imaging , 2006, Magnetic resonance in medicine.

[15]  Sandeep Mittal,et al.  Identification of calcification with MRI using susceptibility‐weighted imaging: A case study , 2009, Journal of magnetic resonance imaging : JMRI.

[16]  Rohit Bakshi,et al.  Magnetic Resonance Imaging of Iron Deposition in Neurological Disorders , 2006, Topics in magnetic resonance imaging : TMRI.

[17]  E Mark Haacke,et al.  Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults , 2010, Journal of magnetic resonance imaging : JMRI.

[18]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[19]  J. Stankiewicz,et al.  Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.

[20]  G. Bartzokis,et al.  Increased basal ganglia iron levels in Huntington disease. , 1999, Archives of neurology.

[21]  Jim Mintz,et al.  Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.

[22]  Jim Mintz,et al.  Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases , 2005, Alzheimer's & Dementia.

[23]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[24]  Nick C Fox,et al.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.

[25]  R A Knight,et al.  MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. , 1999, Radiology.

[26]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[27]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[28]  Maria Grazia Bruzzone,et al.  Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. , 2009, Radiology.

[29]  H. Ischiropoulos,et al.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association? , 2003, The Journal of clinical investigation.

[30]  Daniela Berg,et al.  Role of Iron in Neurodegenerative Disorders , 2006, Topics in magnetic resonance imaging : TMRI.

[31]  Xiaojun Xu,et al.  Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study , 2008, NeuroImage.

[32]  G. Pearlson,et al.  Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[33]  R M Henkelman,et al.  MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. , 1993, AJNR. American journal of neuroradiology.

[34]  G. Pearlson,et al.  Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.

[35]  Liang Xuan,et al.  Magnetic field correlation as a measure of iron‐generated magnetic field inhomogeneities in the brain , 2009, Magnetic resonance in medicine.

[36]  P D Griffiths,et al.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. , 2000, Brain : a journal of neurology.

[37]  Jane S. Paulsen,et al.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.

[38]  R. Roos,et al.  Nuclear membrane indentations in Huntington's chorea , 1983, Journal of the Neurological Sciences.

[39]  G. Bartzokis,et al.  MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. , 2000, Cellular and molecular biology.

[40]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[41]  Jeroen van der Grond,et al.  Early atrophy of pallidum and accumbens nucleus in Huntington’s disease , 2010, Journal of Neurology.

[42]  R. Roos,et al.  MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease , 2010, PLoS currents.

[43]  M. MacDonald,et al.  CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.